A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms
Clinical trial NCT05407064 · COMPLETED
Trial details
- NCT number
- NCT05407064
- Sponsor
- Definium Therapeutics US, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-24
- Primary completion
- 2023-10-06
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.